Test ID: AGXT
Alanine:Glyoxylate Aminotransferase (AGXT) Mutation Analysis (G170R), Blood
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
83643
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Identifying patients with the pyridoxine responsive form of PH1
Determining the presence of the Gly170Arg (G170R) mutation in the AGXT gene
Carrier testing of at-risk family members
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Detects Gly170Arg mutation associated with assessment of pyridoxine responsiveness only. This test is not diagnostic for hyperoxaluria type I.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Direct Mutation Analysis by Polymerase Chain Reaction (PCR)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
AGXT Mutation Analysis (G170R)
Aliases Lists additional common names for a test, as an aid in searching
Hyperoxaluria
PH1 (Primary Hyperoxaluria Type 1)
PH1 (Primary Hyperoxaluria Type 1)
External
link
PDF
document
Excel
document
Word
document